Skip to main content
Log in

Second generation cryoballoon ablation for persistent atrial fibrillation: an updated meta-analysis

  • Original Paper
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Background

Catheter ablation is an established treatment option for patients with symptomatic atrial fibrillation (AF). The cornerstone of AF ablation is pulmonary vein isolation (PVI). The second-generation cryoballoon (2G-CB) has shown non-inferiority to radiofrequency (RF) ablation in paroxysmal AF in several trials. Growing evidence suggests that 2G-CB is also effective in patients with persistent AF (perAF). The aim of this study was to summarize and analyze available data on safety and mid-term (≥ 12 months) efficacy of PVI using 2G-CB in patients with perAF.

Methods

We did a search in PubMed, Web of Science, Cochrane Library, and clinicaltrials.gov in December 2016 for studies of 2G-CB ablation for perAF. Studies reporting clinical success rates at a follow-up (FU) of ≥ 12 months were included. Success was defined as freedom from any atrial arrhythmia lasting > 30 s after an initial blanking period of 3 months. Acute success and complication rates were also assessed. Data were analyzed applying random-effects model.

Results

A total of 917 patients from 11 studies meeting study inclusion criteria were analyzed. After a mean FU of 16.7 ± 3.0 months, 68.9% were free from recurrences [95% confidence interval (CI) 63.4–74.7%]. Overall acute success rate was 99.7% (95% CI 99.2–100%). Complications occurred in 5.5% (95% CI 2.4–9.6%). Vascular access complications were the most frequent 3.3% (95% CI 1.5–5.6%). The rate of phrenic nerve palsy/injury was 2.09% (95% CI 0.8–3.9%). No death, stroke or myocardial infarction was reported.

Conclusion

The 2G-CB seems to be safe and effective in the treatment of perAF in the mid-term.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

2G-CB:

Second-generation cryoballoon

AAD:

Antiarrhythmic drugs

AF:

Atrial fibrillation

BP:

Blanking period

CB:

Cryoballoon

FU:

Follow-up

Pts:

Patients

PxAF:

Paroxysmal AF

PerAF:

Persistent AF

PNP:

Phrenic nerve palsy/injury

PV:

Pulmonary vein

PVI:

Pulmonary vein isolation

RF:

Radiofrequency

References

  1. Arbelo E, Brugada J, Lundqvist CB, Laroche C, Kautzner J, Pokushalov E, Raatikainen P, Efremidis M, Hindricks G, Barrera A, Maggioni A, Tavazzi L, Dagres N (2017) Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry. Eur Heart J. doi:10.1093/eurheartj/ehw564

    PubMed  Google Scholar 

  2. Aryana A, Singh SM, Kowalski M, Pujara DK, Cohen AI, Singh SK, Aleong RG, Banker RS, Fuenzalida CE, Prager NA, Bowers MR, D’Avila A, O’Neill PG (2015) Acute and long-term outcomes of catheter ablation of atrial fibrillation using the second-generation cryoballoon versus open-irrigated radiofrequency: a multicenter experience. J Cardiovasc Electrophysiol 26:832–839. doi:10.1111/jce.12695

    Article  PubMed  Google Scholar 

  3. Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98:946–952

    Article  CAS  PubMed  Google Scholar 

  4. Buiatti A, von Olshausen G, Barthel P, Schneider S, Luik A, Kaess B, Laugwitz KL, Hoppmann P (2016) Cryoballoon vs. radiofrequency ablation for paroxysmal atrial fibrillation: an updated meta-analysis of randomized and observational studies. Europace. doi:10.1093/europace/euw262

    PubMed  Google Scholar 

  5. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D, Heart Rhythm Society Task Force on C, Surgical Ablation of Atrial F (2012) 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm 9:632–696 e621 doi:10.1016/j.hrthm.2011.12.016

    Article  PubMed  Google Scholar 

  6. Cardoso R, Mendirichaga R, Fernandes G, Healy C, Lambrakos LK, Viles-Gonzalez JF, Goldberger JJ, Mitrani RD (2016) Cryoballoon versus radiofrequency catheter ablation in atrial fibrillation: a meta-analysis. J Cardiovasc Electrophysiol 27:1151–1159. doi:10.1111/jce.13047

    Article  PubMed  Google Scholar 

  7. Chen CF, Gao XF, Duan X, Chen B, Liu XH, Xu YZ (2017) Comparison of catheter ablation for paroxysmal atrial fibrillation between cryoballoon and radiofrequency: a meta-analysis. J Interv Card Electrophysiol. doi:10.1007/s10840-016-0220-8

    PubMed Central  Google Scholar 

  8. Cheng X, Hu Q, Zhou C, Liu LQ, Chen T, Liu Z, Tang X (2015) The long-term efficacy of cryoballoon vs irrigated radiofrequency ablation for the treatment of atrial fibrillation: a meta-analysis. Int J Cardiol 181:297–302. doi:10.1016/j.ijcard.2014.12.002

    Article  PubMed  Google Scholar 

  9. Ciconte G, Baltogiannis G, de Asmundis C, Sieira J, Conte G, Di Giovanni G, Saitoh Y, Irfan G, Mugnai G, Hunuk B, Chierchia GB, Brugada P (2015) Circumferential pulmonary vein isolation as index procedure for persistent atrial fibrillation: a comparison between radiofrequency catheter ablation and second-generation cryoballoon ablation. Europace 17:559–565. doi:10.1093/europace/euu350

    Article  PubMed  Google Scholar 

  10. Ciconte G, de Asmundis C, Sieira J, Conte G, Di Giovanni G, Mugnai G, Saitoh Y, Baltogiannis G, Irfan G, Coutino-Moreno HE, Hunuk B, Velagic V, Brugada P, Chierchia GB (2015) Single 3-minute freeze for second-generation cryoballoon ablation: one-year follow-up after pulmonary vein isolation. Heart Rhythm 12:673–680. doi:10.1016/j.hrthm.2014.12.026

    Article  PubMed  Google Scholar 

  11. Ciconte G, Ottaviano L, de Asmundis C, Baltogiannis G, Conte G, Sieira J, Di Giovanni G, Saitoh Y, Irfan G, Mugnai G, Storti C, Montenero AS, Chierchia GB, Brugada P (2015) Pulmonary vein isolation as index procedure for persistent atrial fibrillation: one-year clinical outcome after ablation using the second-generation cryoballoon. Heart Rhythm 12:60–66. doi:10.1016/j.hrthm.2014.09.063

    Article  PubMed  Google Scholar 

  12. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188

    Article  CAS  PubMed  Google Scholar 

  13. Di Giovanni G, Wauters K, Chierchia GB, Sieira J, Levinstein M, Conte G, de Asmundis C, Baltogiannis G, Saitoh Y, Ciconte G, Julia J, Mugnai G, Irfan G, Brugada P (2014) One-year follow-up after single procedure cryoballoon ablation: a comparison between the first and second generation balloon. J Cardiovasc Electrophysiol 25:834–839. doi:10.1111/jce.12409

    Article  PubMed  Google Scholar 

  14. Furnkranz A, Bordignon S, Dugo D, Perotta L, Gunawardene M, Schulte-Hahn B, Nowak B, Schmidt B, Chun JK (2014) Improved 1-year clinical success rate of pulmonary vein isolation with the second-generation cryoballoon in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 25:840–844. doi:10.1111/jce.12417

    Article  PubMed  Google Scholar 

  15. Guhl EN, Siddoway D, Adelstein E, Voigt A, Saba S, Jain SK (2016) Efficacy of cryoballoon pulmonary vein isolation in patients with persistent atrial fibrillation. J Cardiovasc Electrophysiol 27:423–427. doi:10.1111/jce.12924

    Article  PubMed  Google Scholar 

  16. He X, Chen Y, Zhou Y, Huang Y, He J (2016) One-year clinical outcome of pulmonary vein isolation using the second-generation cryoballoon: a meta-analysis. Pacing Clin Electrophysiol 39:182–189. doi:10.1111/pace.12787

    Article  PubMed  Google Scholar 

  17. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560. doi:10.1136/bmj.327.7414.557

    Article  PubMed  PubMed Central  Google Scholar 

  18. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P, Agewall S, Camm J, Baron Esquivias G, Budts W, Carerj S, Casselman F, Coca A, De Caterina R, Deftereos S, Dobrev D, Ferro JM, Filippatos G, Fitzsimons D, Gorenek B, Guenoun M, Hohnloser SH, Kolh P, Lip GY, Manolis A, McMurray J, Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, Tamargo JL, Taylor CJ, Van Gelder IC, Voors AA, Windecker S, Zamorano JL, Zeppenfeld K (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace 18:1609–1678. doi:10.1093/europace/euw295

    Article  PubMed  Google Scholar 

  19. Knecht S, Kuhne M, Osswald S, Sticherling C (2014) Quantitative assessment of a second-generation cryoballoon ablation catheter with new cooling technology—a perspective on potential implications on outcome. J Interv Card Electrophysiol 40:17–21. doi:10.1007/s10840-014-9883-1

    Article  PubMed  Google Scholar 

  20. Koektuerk B, Yorgun H, Hengeoez O, Turan CH, Dahmen A, Yang A, Bansmann PM, Gorr E, Hoppe C, Turan RG, Horlitz M (2015) Cryoballoon ablation for pulmonary vein isolation in patients with persistent atrial fibrillation: one-year outcome using second generation cryoballoon. Circ Arrhythm Electrophysiol 8:1073–1079. doi:10.1161/CIRCEP.115.002776

    Article  PubMed  Google Scholar 

  21. Kuniss M, Greiss H, Pajitnev D, Akkaya E, Deubner N, Hain A, Bodammer L, Berkowitsch A, Chierchia GB, Hamm CW, Neumann T (2016) Cryoballoon ablation of persistent atrial fibrillation: feasibility and safety of left atrial roof ablation with generation of conduction block in addition to antral pulmonary vein isolation. Europace. doi:10.1093/europace/euw146

    PubMed  Google Scholar 

  22. Lemes C, Wissner E, Lin T, Mathew S, Deiss S, Rillig A, Heeger C, Wohlmuth P, Reissmann B, Tilz R, Ouyang F, Kuck KH, Metzner A (2016) One-year clinical outcome after pulmonary vein isolation in persistent atrial fibrillation using the second-generation 28 mm cryoballoon: a retrospective analysis. Europace 18:201–205. doi:10.1093/europace/euv092

    Article  PubMed  Google Scholar 

  23. Metzner A, Heeger CH, Wohlmuth P, Reissmann B, Rillig A, Tilz RR, Mathew S, Lemes C, Deiss S, Maurer T, Saguner A, Ouyang F, Kuck KH, Wissner E (2016) Two-year outcome after pulmonary vein isolation using the second-generation 28-mm cryoballoon: lessons from the bonus freeze protocol. Clin Res Cardiol 105:72–78. doi:10.1007/s00392-015-0890-8

    Article  PubMed  Google Scholar 

  24. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8:336–341. doi:10.1016/j.ijsu.2010.02.007

    Article  PubMed  Google Scholar 

  25. Mont L, Bisbal F, Hernandez-Madrid A, Perez-Castellano N, Vinolas X, Arenal A, Arribas F, Fernandez-Lozano I, Bodegas A, Cobos A, Matia R, Perez-Villacastin J, Guerra JM, Avila P, Lopez-Gil M, Castro V, Arana JI, Brugada J (2014) Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study). Eur Heart J 35:501–507. doi:10.1093/eurheartj/eht457

    Article  PubMed  Google Scholar 

  26. Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, Newton-Cheh C, Lubitz SA, Magnani JW, Ellinor PT, Seshadri S, Wolf PA, Vasan RS, Benjamin EJ, Levy D (2015) 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet 386:154–162. doi:10.1016/S0140-6736(14)61774-8

    Article  PubMed  PubMed Central  Google Scholar 

  27. Scott PA, Silberbauer J, Murgatroyd FD (2016) The impact of adjunctive complex fractionated atrial electrogram ablation and linear lesions on outcomes in persistent atrial fibrillation: a meta-analysis. Europace 18:359–367. doi:10.1093/europace/euv351

    Article  PubMed  Google Scholar 

  28. Straube F, Hartl S, Dorwarth U, Wankerl M, Bunz B, Ebersberger U, Hoffmann E (2016) Cryoballoon ablation for persistent atrial fibrillation–large single-center experience. J Cardiol 68:492–497. doi:10.1016/j.jjcc.2016.02.007

    Article  PubMed  Google Scholar 

  29. Su WW, Alzubaidi M, Tseng R, Jebaily N, Lin YJ, Wang PJ (2016) Novel usage of the cryoballoon catheter to achieve large area atrial substrate modification in persistent and long-standing persistent atrial fibrillation. J Interv Card Electrophysiol 46:275–285. doi:10.1007/s10840-016-0120-ytry

    Article  PubMed  Google Scholar 

  30. Tscholl V, Lsharaf AK, Lin T, Bellmann B, Biewener S, Nagel P, Suhail S, Lenz K, Landmesser U, Roser M, Rillig A (2016) Two years outcome in patients with persistent atrial fibrillation after pulmonary vein isolation using the second-generation 28-mm cryoballoon. Heart Rhythm 13:1817–1822. doi:10.1016/j.hrthm.2016.05.022

    Article  PubMed  Google Scholar 

  31. Verma A, Jiang CY, Betts TR, Chen J, Deisenhofer I, Mantovan R, Macle L, Morillo CA, Haverkamp W, Weerasooriya R, Albenque JP, Nardi S, Menardi E, Novak P, Sanders P (2015) Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med 372:1812–1822. doi:10.1056/NEJMoa1408288

    Article  PubMed  Google Scholar 

  32. Wallace BC, Dahabreh IJ, Trikalinos TA, Lau J, Trow P, Schmid CH (2012) Closing the gap between methodologists and end-users: R as a computational back-end. J Stat Softw 49:15 doi:10.18637/jss.v049.i05

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hazem Omran.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 184 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Omran, H., Gutleben, KJ., Molatta, S. et al. Second generation cryoballoon ablation for persistent atrial fibrillation: an updated meta-analysis. Clin Res Cardiol 107, 182–192 (2018). https://doi.org/10.1007/s00392-017-1171-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-017-1171-5

Keywords

Navigation